controlling nosocomial transmission of methicillin-resistant Staphylococcus aureus in resource limited setting with high endemicity. PLOS ONE 2014;9:e100493. 3. National Antimicrobial Resistance Surveillance Center Thailand. Antibiogram 2014: all specimens. National Antimicrobial Resistance Surveillance Center Thailand website. http://narst.dmsc. moph.go.th/antibiograms/2014/2014all.pdf. Published 2015. Accessed January 25, 2016. 4. Wongcharoen S, Luxamesathaporn P, Khawcharoenporn T, Rujanavech S, Warren DK, Apisarnthanarak A. Impact of cohorting for multidrug-resistant organisms with and without real-time feedback. Infect Control Hosp Epidemiol 2013;34:648–650. 5. Apisarnthanarak A, Pinitchai U, Warachan B, Warren DK, Khawcharoenporn T, Hayden MK. Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai intensive care unit: an analysis before and after extensive flooding. Am J Infect Control 2014;42:116–121. 6. Sellick JA Jr. The use of statistical process control charts in hospital epidemiology. Infect Control Hosp Epidemiol 1993;14: 649–656. 7. Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008;47:760–767. 8. Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006;42:768–775. 9. Lee BY, Yilmaz SL, Wong KF, et al. Modeling the regional spread and control of vancomycin-resistant enterococci. Am J Infect Control 2013;41:668–673. 10. National Antimicrobial Resistance Surveillance Center Thailand. Antibiogram 2012: all specimens. National Antimicrobial Resistance Surveillance Center Thailand website. http://narst.dmsc. moph.go.th/antibiograms/2012/2012all.pdf. Published 2013. Accessed January 25, 2016.
[1]
M. Iwamoto,et al.
Infection Prevention Practices in Neonatal Intensive Care Units Reporting to the National Healthcare Safety Network
,
2014,
Infection Control & Hospital Epidemiology.
[2]
M. Rupp,et al.
Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update
,
2014,
Infection Control & Hospital Epidemiology.
[3]
C. Quach,et al.
Chlorhexidine Bathing in a Tertiary Care Neonatal Intensive Care Unit: Impact on Central Line–Associated Bloodstream Infections
,
2014,
Infection Control & Hospital Epidemiology.
[4]
M. Rupp,et al.
Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update
,
2014,
Infection Control & Hospital Epidemiology.
[5]
C. Bearer,et al.
Chlorhexidine inhibits L1 cell adhesion molecule–mediated neurite outgrowth in vitro
,
2014,
Pediatric Research.
[6]
S. Coffin,et al.
Beyond the Bundle: A Survey of Central Line–Associated Bloodstream Infection Prevention Practices Used in US and Canadian Pediatric Hospitals
,
2013,
Infection Control & Hospital Epidemiology.
[7]
S. Aucott,et al.
Absorption and Tolerability of Aqueous Chlorhexidine Gluconate Used for Skin Antisepsis Prior to Catheter Insertion in Preterm Neonates
,
2013,
Journal of Perinatology.
[8]
P. Tamma,et al.
Chlorhexidine Use in the Neonatal Intensive Care Unit: Results from a National Survey
,
2010,
Infection Control & Hospital Epidemiology.
[9]
S. Saint,et al.
Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals
,
2008,
Infection Control & Hospital Epidemiology.
[10]
T. Perl,et al.
Chlorhexidine: expanding the armamentarium for infection control and prevention.
,
2008,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.